Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution
about
Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family membersBiochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzymeMembrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMPEpilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injuryCharacterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial originGelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomasHepatoprotective effect of MMP-19 deficiency in a mouse model of chronic liver fibrosisEvaluation of some newer matrix metalloproteinasesMatrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP)Molecular characterization of porcine MMP19 and MMP23B genes and its association with immune traitsCloning and characterization of a novel matrix metalloproteinase (MMP), CMMP, from chicken embryo fibroblasts. CMMP, Xenopus XMMP, and human MMP19 have a conserved unique cysteine in the catalytic domainCloning of MMP-26Enamelysin mRNA displays a developmentally defined pattern of expression and encodes a protein which degrades amelogenin.ADAM-10 message is expressed in human articular cartilage.MMP19 is essential for T cell development and T cell-mediated cutaneous immune responsesMatrix metalloproteinases and their inhibitors in tumour growth and invasion.Progress in matrix metalloproteinase research.The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer.Matrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and humansPhysiological roles of matrix metalloproteinases: implications for tumor growth and metastasis.Proteinases in developing dental enamel.Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase.Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.Production of active mammalian and viral proteases in bacterial expression systems.Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient miceMatrix metalloproteinases in cancer: prognostic markers and therapeutic targets.Proteolytic events of wound-healing--coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules.A glimpse of matrix metalloproteinases in diabetic nephropathy.Physiology and pathophysiology of matrix metalloproteases.Proteolytic host cell enzymes in gingival crevice fluid.Matrix metalloproteinases: protective roles in cancer.Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritisMatrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.Downregulation of matrix metalloproteinase‑19 induced by respiratory syncytial viral infection affects the interaction between epithelial cells and fibroblasts.Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular diseaseExpression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas.Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse.Overexpression of asparagine synthetase and matrix metalloproteinase 19 confers cisplatin sensitivity in nasopharyngeal carcinoma cells.Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications.
P2860
Q22001456-3E2754D8-E9C0-463C-87FB-DE5A5D7350D2Q22254090-9716947C-B6CA-4F9D-948B-D1C2138A6CE8Q24290409-70B30AA6-38F4-4BCA-9D11-D7C3686BF64CQ24290646-3A26B3ED-0D22-4AE3-A6BC-6350FC3A4143Q24532807-B35B64FD-A798-44D4-B7A3-146E59BF7821Q24649857-D22D01F0-A648-4D01-A987-CE1AA6D42135Q27316480-804FE4BA-483D-454D-94CC-07AB2D4C03EEQ28140362-52200CDB-65A4-4EAB-A9A1-0141712DD66BQ28142482-7A7CD38E-EA6A-48B7-BF5D-035AE6AC8F29Q28248417-8342A499-36AA-431C-AFE8-BC5F7AB8C146Q28610368-BD563BFD-25D8-42BF-A312-39780B36D8C6Q29011231-23F9BD6F-A5D3-4DD6-8437-18151A6AF3DBQ30657484-5BBDA975-1A62-4E4D-9F47-ECB7E3765C64Q32062596-97DB3EF0-6339-402E-AF81-34C54C968DBAQ33340257-DD97E77C-AD3A-43CE-92CD-E6F7FEA5DE9CQ33603385-BC5B08A9-C851-4985-AD44-83502696EF8EQ33608536-E26BCD90-E733-4577-9C58-E25BDA6F0473Q33693020-4917E049-308F-48D0-95C2-134486016E16Q33745690-79235ABB-CCDE-484B-ABEA-37F3E408A4AAQ33760250-C369F8E8-F07A-44F2-A6F6-ABB671B6E42CQ33817047-1E10D574-D3F7-4EDD-AADA-FA1F63D2F7BAQ33880837-8CB7CDC9-C733-47CD-9D81-36BF1DE940C1Q33970473-E5F9E769-B920-48AE-A704-81FBE5A37353Q34187840-6DFE024F-A340-40F5-933A-F34E0B837CEAQ34346225-EDE0C9AB-EE52-4052-90DD-524A2360ED56Q34616803-CA396419-A2EF-4F5A-B122-02D20A0E33E9Q34632691-535810A1-0863-4AE3-88B9-11703D6C3626Q34796034-5709C85F-68C4-42A8-BCD4-01B3B2FA43A1Q35007715-F8A46DE4-697A-4B86-83DB-83165C57D331Q35092086-6B6BDE10-B240-4E92-AB75-FCFA6CBFA23BQ35216059-1A96AA8D-170E-42C6-B1AB-AD66E2CF34F2Q35548302-959435DC-EBB3-4D25-8444-4EF1906B8831Q35549401-F77349DA-C61C-4AF2-A49B-C23E57B2A6A8Q36390230-04E0EC1C-EC83-4690-A38D-0F25E33DB7CDQ36477722-DE071C35-EFDC-496E-AD4C-308C6701D7FEQ36617718-2D5EFADA-5F41-4F05-9EF4-0E93EE9F1281Q36700657-D2109956-110E-4B33-95AE-9C775D356EDAQ37159684-AD4E9D05-4D54-46C8-BD4A-54ECA4FAF05FQ37227757-C05AD44B-575A-42B3-A610-7ECB2C204D8EQ37993746-F1E4F1AE-584C-498D-B5B4-2B1CA71517E7
P2860
Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution
description
1997 nî lūn-bûn
@nan
1997 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Identification and characteriz ...... ation, and tissue distribution
@ast
Identification and characteriz ...... ation, and tissue distribution
@en
Identification and characteriz ...... ation, and tissue distribution
@en-gb
Identification and characteriz ...... ation, and tissue distribution
@nl
type
label
Identification and characteriz ...... ation, and tissue distribution
@ast
Identification and characteriz ...... ation, and tissue distribution
@en
Identification and characteriz ...... ation, and tissue distribution
@en-gb
Identification and characteriz ...... ation, and tissue distribution
@nl
prefLabel
Identification and characteriz ...... ation, and tissue distribution
@ast
Identification and characteriz ...... ation, and tissue distribution
@en
Identification and characteriz ...... ation, and tissue distribution
@en-gb
Identification and characteriz ...... ation, and tissue distribution
@nl
P2093
P2860
P50
P356
P1476
Identification and characteriz ...... ation, and tissue distribution
@en
P2093
P2860
P304
P356
10.1074/JBC.272.7.4281
P407
P577
1997-02-01T00:00:00Z